ADVANCED CARDIAC RHYTHM INTERPRETATION
CERTIFICATION COMPLETE EXAM QUESTIONS AND VERIFIED
ANSWERS | 2026–2027 LATEST UPDATE | GUARANTEED
PASS | DETAILED RATIONALES | FULL STUDY GUIDE | EXAM
PREP | PRACTICE TEST | CERTIFICATION PREPARATION
1. A 68-year-old patient with a history of hypertension presents with palpitations and mild
dyspnea. The cardiac monitor shows a narrow-complex tachycardia at a rate of 180 bpm with no
visible P waves. Which of the following is the most appropriate initial action?
A. Administer adenosine 6 mg rapid IV push
B. Perform synchronized cardioversion at 100 J
C. Obtain a 12-lead ECG to confirm the rhythm
D. Initiate an amiodarone infusion
Correct Answer: C. Obtain a 12-lead ECG to confirm the rhythm
Rationale: Before administering any intervention, it is crucial to have a 12-lead ECG for accurate
rhythm diagnosis and to identify whether the tachycardia is regular or irregular. Adenosine (A) is
appropriate for regular narrow-complex tachycardias like AVNRT or AVRT, but is contraindicated in
irregular rhythms like atrial fibrillation. Synchronized cardioversion (B) is indicated for unstable
patients with altered mental status, chest pain, or hypotension. Amiodarone (D) is a second-line
agent for rate control in narrow-complex tachycardias and should not be the initial step without a
confirmed diagnosis. The initial step is always diagnostic confirmation.
2. What is the earliest sign of digoxin toxicity on a cardiac rhythm strip?
A. Bidirectional ventricular tachycardia
B. Atrial tachycardia with block
C. Frequent premature ventricular contractions (PVCs)
D. ST-segment depression with a "scooped" appearance
Correct Answer: D. ST-segment depression with a "scooped" appearance
Rationale: The earliest ECG manifestation of digoxin toxicity is the characteristic ST-segment
depression with a "scooped" or "sagging" appearance, often described as a "reverse tick" sign. This
effect is due to digoxin's action on the Na-K-ATPase pump, altering the action potential. While
bidirectional ventricular tachycardia (A) and atrial tachycardia with block (B) are classic signs of
severe toxicity, they are not the earliest findings. Frequent PVCs (C) can occur but are less specific and
often appear later in the toxicity spectrum.
3. A 45-year-old patient with no prior cardiac history is in the ED with a heart rate of 220 bpm. The
monitor shows a regular, wide-complex tachycardia. The patient is alert and has a blood pressure
of 110/70 mmHg. What is the most appropriate next step?
,A. Administer amiodarone 150 mg IV over 10 minutes
B. Perform immediate synchronized cardioversion
C. Administer adenosine 6 mg IV push
D. Begin a continuous infusion of procainamide
Correct Answer: C. Administer adenosine 6 mg IV push
Rationale: In a stable patient with a regular, wide-complex tachycardia of unknown origin, adenosine
is recommended as a diagnostic and therapeutic tool. If the rhythm is supraventricular tachycardia
with aberrancy, adenosine will terminate it. If it is ventricular tachycardia, adenosine will have no
effect but is generally safe. Amiodarone (A) and procainamide (D) are antiarrhythmic options for
stable VT but are not the first diagnostic step. Synchronized cardioversion (B) is reserved for unstable
patients or when drug therapy fails.
4. When analyzing a 12-lead ECG, which of the following findings is most indicative of an acute
inferior wall myocardial infarction?
A. ST-segment elevation in leads V1–V4
B. ST-segment elevation in leads II, III, and aVF
C. ST-segment depression in leads I and aVL
D. Pathological Q waves in leads V5–V6
Correct Answer: B. ST-segment elevation in leads II, III, and aVF
Rationale: Leads II, III, and aVF view the inferior surface of the heart, which is supplied by the right
coronary artery in most patients. ST-segment elevation in these leads is indicative of an acute inferior
wall MI. ST-segment elevation in leads V1–V4 (A) suggests an anterior MI. ST-segment depression in
leads I and aVL (C) is often a reciprocal change to inferior wall injury. Pathological Q waves in V5–V6
(D) indicate a prior or evolving lateral wall MI.
5. A patient with a permanent dual-chamber pacemaker presents for a routine checkup. The ECG
shows paced ventricular complexes that occur at a rate of 60 bpm but do not follow a paced P
wave. What is the most likely pacemaker malfunction?
A. Failure to capture
B. Failure to sense
C. Failure to pace
D. Pacemaker-mediated tachycardia
Correct Answer: A. Failure to capture
Rationale: The scenario describes a situation where the pacemaker fires (evidenced by the pacing
spike) but the ventricular complex does not follow, indicating a failure to capture the myocardium.
Failure to sense (B) would result in asynchronous pacing, with pacing spikes appearing on T waves or
during the QRS complex. Failure to pace (C) would show no pacing spikes at all. Pacemaker-mediated
tachycardia (D) is a reentrant tachycardia involving the pacemaker and is characterized by a very fast
paced rate.
,6. A patient with a suspected pulmonary embolism has an ECG showing sinus tachycardia, an
S1Q3T3 pattern, and new incomplete right bundle branch block. What is the primary mechanism
for these ECG changes?
A. Right ventricular strain and dilation
B. Left ventricular hypertrophy
C. Increased sympathetic tone due to pain
D. Hypoxia-induced conduction delay
Correct Answer: A. Right ventricular strain and dilation
Rationale: A massive pulmonary embolism increases pulmonary vascular resistance, causing acute
right ventricular pressure overload. This right ventricular strain and dilation leads to the classic,
though not highly sensitive, ECG findings of sinus tachycardia, S1Q3T3 (an S wave in lead I, Q wave in
lead III, and inverted T wave in lead III), and incomplete right bundle branch block. Left ventricular
hypertrophy (B) does not cause these findings. While increased sympathetic tone (C) can cause sinus
tachycardia, it doesn't explain the other changes. Hypoxia (D) can prolong the QT interval but is not
the primary mechanism for the specific pattern described.
7. Which of the following medications is most likely to cause a prolonged QT interval and increase
the risk of Torsades de Pointes?
A. Metoprolol
B. Diltiazem
C. Sotalol
D. Lidocaine
Correct Answer: C. Sotalol
Rationale: Sotalol is a class III antiarrhythmic that blocks potassium channels, which significantly
prolongs the QT interval and increases the risk of Torsades de Pointes. Metoprolol (A) is a beta-
blocker that primarily affects the AV node and does not significantly prolong the QT interval.
Diltiazem (B) is a calcium channel blocker that slows AV conduction. Lidocaine (D) is a class IB agent
that shortens the action potential and is not associated with significant QT prolongation.
8. A 72-year-old patient is found to have atrial fibrillation with a ventricular response of 150 bpm.
The patient is asymptomatic but has a history of heart failure with reduced ejection fraction.
Which of the following is the most appropriate initial agent for rate control?
A. Metoprolol succinate
B. Diltiazem
C. Digoxin
D. Amiodarone
Correct Answer: A. Metoprolol succinate
Rationale: Beta-blockers, such as metoprolol succinate, are the first-line agents for rate control in
atrial fibrillation, especially in patients with heart failure with reduced ejection fraction (HFrEF), as
they are the only agents that have been shown to reduce mortality in this population. Diltiazem (B) is
a non-dihydropyridine calcium channel blocker; its negative inotropic effects make it a poor choice in
, HFrEF. Digoxin (C) is often used as a second-line agent for rate control in HFrEF but is not the initial
drug of choice due to its narrow therapeutic window and slower onset. Amiodarone (D) is a rhythm-
control agent and not typically used for rate control in this setting.
9. During a code blue, a patient is in ventricular fibrillation. After the second shock, the team
leader instructs you to give a medication. Which is the correct first-line antiarrhythmic and its
appropriate dose?
A. Amiodarone 150 mg IV push
B. Lidocaine 1-1.5 mg/kg IV push
C. Epinephrine 1 mg IV push
D. Amiodarone 300 mg IV push
Correct Answer: D. Amiodarone 300 mg IV push
Rationale: According to the AHA guidelines, amiodarone 300 mg (or 5 mg/kg) is the first-line
antiarrhythmic for ventricular fibrillation/pulseless ventricular tachycardia that is refractory to
defibrillation. A 150 mg dose (A) is used as a rapid bolus for stable wide-complex tachycardia.
Lidocaine (B) is considered a second-line agent in this scenario. Epinephrine (C) is given every 3-5
minutes but is not an antiarrhythmic; it is given to increase coronary perfusion pressure and is
administered after the first shock.
10. Which ECG finding is a key diagnostic criterion for hypertrophic cardiomyopathy?
A. Deep Q waves in leads V1–V3
B. Deep, narrow Q waves in the inferior and lateral leads
C. Prolonged PR interval with a delta wave
D. ST-segment elevation in the precordial leads
Correct Answer: B. Deep, narrow Q waves in the inferior and lateral leads
Rationale: Hypertrophic cardiomyopathy (HCM) is characterized by asymmetrical septal hypertrophy,
leading to deep, narrow (<40 ms) Q waves in the inferior (II, III, aVF) and lateral (I, aVL, V4-V6) leads.
These Q waves are often accompanied by LVH criteria. Deep Q waves in V1–V3 (A) are more
suggestive of an old anteroseptal MI. A prolonged PR interval with a delta wave (C) is diagnostic of
Wolff-Parkinson-White syndrome. ST-segment elevation in the precordial leads (D) is a marker of
acute myocardial injury or pericarditis.
11. A patient's cardiac monitor shows a sudden change from sinus rhythm to a wide-complex
tachycardia. The rate is 190 bpm, and the patient becomes hypotensive and confused. What is the
immediate next action?
A. Administer adenosine 6 mg IV push
B. Start a lidocaine infusion
C. Perform immediate synchronized cardioversion
D. Administer amiodarone 300 mg IV push
Correct Answer: C. Perform immediate synchronized cardioversion
CERTIFICATION COMPLETE EXAM QUESTIONS AND VERIFIED
ANSWERS | 2026–2027 LATEST UPDATE | GUARANTEED
PASS | DETAILED RATIONALES | FULL STUDY GUIDE | EXAM
PREP | PRACTICE TEST | CERTIFICATION PREPARATION
1. A 68-year-old patient with a history of hypertension presents with palpitations and mild
dyspnea. The cardiac monitor shows a narrow-complex tachycardia at a rate of 180 bpm with no
visible P waves. Which of the following is the most appropriate initial action?
A. Administer adenosine 6 mg rapid IV push
B. Perform synchronized cardioversion at 100 J
C. Obtain a 12-lead ECG to confirm the rhythm
D. Initiate an amiodarone infusion
Correct Answer: C. Obtain a 12-lead ECG to confirm the rhythm
Rationale: Before administering any intervention, it is crucial to have a 12-lead ECG for accurate
rhythm diagnosis and to identify whether the tachycardia is regular or irregular. Adenosine (A) is
appropriate for regular narrow-complex tachycardias like AVNRT or AVRT, but is contraindicated in
irregular rhythms like atrial fibrillation. Synchronized cardioversion (B) is indicated for unstable
patients with altered mental status, chest pain, or hypotension. Amiodarone (D) is a second-line
agent for rate control in narrow-complex tachycardias and should not be the initial step without a
confirmed diagnosis. The initial step is always diagnostic confirmation.
2. What is the earliest sign of digoxin toxicity on a cardiac rhythm strip?
A. Bidirectional ventricular tachycardia
B. Atrial tachycardia with block
C. Frequent premature ventricular contractions (PVCs)
D. ST-segment depression with a "scooped" appearance
Correct Answer: D. ST-segment depression with a "scooped" appearance
Rationale: The earliest ECG manifestation of digoxin toxicity is the characteristic ST-segment
depression with a "scooped" or "sagging" appearance, often described as a "reverse tick" sign. This
effect is due to digoxin's action on the Na-K-ATPase pump, altering the action potential. While
bidirectional ventricular tachycardia (A) and atrial tachycardia with block (B) are classic signs of
severe toxicity, they are not the earliest findings. Frequent PVCs (C) can occur but are less specific and
often appear later in the toxicity spectrum.
3. A 45-year-old patient with no prior cardiac history is in the ED with a heart rate of 220 bpm. The
monitor shows a regular, wide-complex tachycardia. The patient is alert and has a blood pressure
of 110/70 mmHg. What is the most appropriate next step?
,A. Administer amiodarone 150 mg IV over 10 minutes
B. Perform immediate synchronized cardioversion
C. Administer adenosine 6 mg IV push
D. Begin a continuous infusion of procainamide
Correct Answer: C. Administer adenosine 6 mg IV push
Rationale: In a stable patient with a regular, wide-complex tachycardia of unknown origin, adenosine
is recommended as a diagnostic and therapeutic tool. If the rhythm is supraventricular tachycardia
with aberrancy, adenosine will terminate it. If it is ventricular tachycardia, adenosine will have no
effect but is generally safe. Amiodarone (A) and procainamide (D) are antiarrhythmic options for
stable VT but are not the first diagnostic step. Synchronized cardioversion (B) is reserved for unstable
patients or when drug therapy fails.
4. When analyzing a 12-lead ECG, which of the following findings is most indicative of an acute
inferior wall myocardial infarction?
A. ST-segment elevation in leads V1–V4
B. ST-segment elevation in leads II, III, and aVF
C. ST-segment depression in leads I and aVL
D. Pathological Q waves in leads V5–V6
Correct Answer: B. ST-segment elevation in leads II, III, and aVF
Rationale: Leads II, III, and aVF view the inferior surface of the heart, which is supplied by the right
coronary artery in most patients. ST-segment elevation in these leads is indicative of an acute inferior
wall MI. ST-segment elevation in leads V1–V4 (A) suggests an anterior MI. ST-segment depression in
leads I and aVL (C) is often a reciprocal change to inferior wall injury. Pathological Q waves in V5–V6
(D) indicate a prior or evolving lateral wall MI.
5. A patient with a permanent dual-chamber pacemaker presents for a routine checkup. The ECG
shows paced ventricular complexes that occur at a rate of 60 bpm but do not follow a paced P
wave. What is the most likely pacemaker malfunction?
A. Failure to capture
B. Failure to sense
C. Failure to pace
D. Pacemaker-mediated tachycardia
Correct Answer: A. Failure to capture
Rationale: The scenario describes a situation where the pacemaker fires (evidenced by the pacing
spike) but the ventricular complex does not follow, indicating a failure to capture the myocardium.
Failure to sense (B) would result in asynchronous pacing, with pacing spikes appearing on T waves or
during the QRS complex. Failure to pace (C) would show no pacing spikes at all. Pacemaker-mediated
tachycardia (D) is a reentrant tachycardia involving the pacemaker and is characterized by a very fast
paced rate.
,6. A patient with a suspected pulmonary embolism has an ECG showing sinus tachycardia, an
S1Q3T3 pattern, and new incomplete right bundle branch block. What is the primary mechanism
for these ECG changes?
A. Right ventricular strain and dilation
B. Left ventricular hypertrophy
C. Increased sympathetic tone due to pain
D. Hypoxia-induced conduction delay
Correct Answer: A. Right ventricular strain and dilation
Rationale: A massive pulmonary embolism increases pulmonary vascular resistance, causing acute
right ventricular pressure overload. This right ventricular strain and dilation leads to the classic,
though not highly sensitive, ECG findings of sinus tachycardia, S1Q3T3 (an S wave in lead I, Q wave in
lead III, and inverted T wave in lead III), and incomplete right bundle branch block. Left ventricular
hypertrophy (B) does not cause these findings. While increased sympathetic tone (C) can cause sinus
tachycardia, it doesn't explain the other changes. Hypoxia (D) can prolong the QT interval but is not
the primary mechanism for the specific pattern described.
7. Which of the following medications is most likely to cause a prolonged QT interval and increase
the risk of Torsades de Pointes?
A. Metoprolol
B. Diltiazem
C. Sotalol
D. Lidocaine
Correct Answer: C. Sotalol
Rationale: Sotalol is a class III antiarrhythmic that blocks potassium channels, which significantly
prolongs the QT interval and increases the risk of Torsades de Pointes. Metoprolol (A) is a beta-
blocker that primarily affects the AV node and does not significantly prolong the QT interval.
Diltiazem (B) is a calcium channel blocker that slows AV conduction. Lidocaine (D) is a class IB agent
that shortens the action potential and is not associated with significant QT prolongation.
8. A 72-year-old patient is found to have atrial fibrillation with a ventricular response of 150 bpm.
The patient is asymptomatic but has a history of heart failure with reduced ejection fraction.
Which of the following is the most appropriate initial agent for rate control?
A. Metoprolol succinate
B. Diltiazem
C. Digoxin
D. Amiodarone
Correct Answer: A. Metoprolol succinate
Rationale: Beta-blockers, such as metoprolol succinate, are the first-line agents for rate control in
atrial fibrillation, especially in patients with heart failure with reduced ejection fraction (HFrEF), as
they are the only agents that have been shown to reduce mortality in this population. Diltiazem (B) is
a non-dihydropyridine calcium channel blocker; its negative inotropic effects make it a poor choice in
, HFrEF. Digoxin (C) is often used as a second-line agent for rate control in HFrEF but is not the initial
drug of choice due to its narrow therapeutic window and slower onset. Amiodarone (D) is a rhythm-
control agent and not typically used for rate control in this setting.
9. During a code blue, a patient is in ventricular fibrillation. After the second shock, the team
leader instructs you to give a medication. Which is the correct first-line antiarrhythmic and its
appropriate dose?
A. Amiodarone 150 mg IV push
B. Lidocaine 1-1.5 mg/kg IV push
C. Epinephrine 1 mg IV push
D. Amiodarone 300 mg IV push
Correct Answer: D. Amiodarone 300 mg IV push
Rationale: According to the AHA guidelines, amiodarone 300 mg (or 5 mg/kg) is the first-line
antiarrhythmic for ventricular fibrillation/pulseless ventricular tachycardia that is refractory to
defibrillation. A 150 mg dose (A) is used as a rapid bolus for stable wide-complex tachycardia.
Lidocaine (B) is considered a second-line agent in this scenario. Epinephrine (C) is given every 3-5
minutes but is not an antiarrhythmic; it is given to increase coronary perfusion pressure and is
administered after the first shock.
10. Which ECG finding is a key diagnostic criterion for hypertrophic cardiomyopathy?
A. Deep Q waves in leads V1–V3
B. Deep, narrow Q waves in the inferior and lateral leads
C. Prolonged PR interval with a delta wave
D. ST-segment elevation in the precordial leads
Correct Answer: B. Deep, narrow Q waves in the inferior and lateral leads
Rationale: Hypertrophic cardiomyopathy (HCM) is characterized by asymmetrical septal hypertrophy,
leading to deep, narrow (<40 ms) Q waves in the inferior (II, III, aVF) and lateral (I, aVL, V4-V6) leads.
These Q waves are often accompanied by LVH criteria. Deep Q waves in V1–V3 (A) are more
suggestive of an old anteroseptal MI. A prolonged PR interval with a delta wave (C) is diagnostic of
Wolff-Parkinson-White syndrome. ST-segment elevation in the precordial leads (D) is a marker of
acute myocardial injury or pericarditis.
11. A patient's cardiac monitor shows a sudden change from sinus rhythm to a wide-complex
tachycardia. The rate is 190 bpm, and the patient becomes hypotensive and confused. What is the
immediate next action?
A. Administer adenosine 6 mg IV push
B. Start a lidocaine infusion
C. Perform immediate synchronized cardioversion
D. Administer amiodarone 300 mg IV push
Correct Answer: C. Perform immediate synchronized cardioversion
